NASDAQ : BCTX
BriaCell Therapeutics Corp. — Financial statements
Healthcare · Biotechnology · Canada
Last price 3.03 USD (Oct 30, 2026, 2:35 PM EDT) · Market cap 26.48M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year August - July; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 6.82M | 6.82M | 6.39M | 6.57M | 8.51M | 7.58M |
| Research & Development | 29.24M | 29.24M | 20.81M | 26.76M | 14.76M | 7.71M |
| Operating Expenses | 36.05M | 36.05M | 27.20M | 33.33M | 23.27M | 15.29M |
| Operating Income | -36.05M | -36.05M | -27.20M | -33.33M | -23.27M | -15.29M |
| Interest Expense | -36.98K | -979.00 | ||||
| Interest & Investment Income | 119.96K | 288.02K | 891.21K | 136.73K | ||
| Earnings From Equity Investments | -263.48K | -263.48K | -224.21K | -106.51K | ||
| Currency Exchange Gain (Loss) | -24.94K | -25.45K | -40.87K | -30.73K | ||
| Other Non Operating Income (Expenses) | 900.20K | 900.20K | 758.36K | 28.24M | 2.12M | -11.65M |
| EBT Excluding Unusual Items | -35.42M | -35.42M | -26.61M | -4.93M | -20.30M | -26.84M |
| Gain (Loss) on Sale of Investments | 92.23K | 92.23K | 56.47K | |||
| Pretax Income | -35.33M | -35.33M | -26.56M | -4.93M | -20.30M | -26.84M |
| Earnings From Continuing Operations | -35.33M | -35.33M | -26.56M | -4.93M | -20.30M | -26.84M |
| Minority Interest in Earnings | 421.03K | 421.03K | 244.27K | 140.08K | ||
| Net Income | -34.90M | -34.90M | -26.31M | -4.79M | -20.30M | -26.84M |
| Net Income to Common | -34.90M | -34.90M | -26.31M | -4.79M | -20.30M | -26.84M |
| Shares Outstanding (Basic) | 5.01M | 5.01M | 423.11K | 109.70K | 104.13K | 103.29K |
| Shares Outstanding (Diluted) | 5.01M | 5.01M | 423.11K | 109.70K | 104.13K | 103.29K |
| EPS (Basic) | -6.97 | -6.97 | -62.19 | -43.68 | -194.97 | -259.83 |
| EPS (Diluted) | -6.97 | -6.97 | -62.19 | -43.68 | -194.97 | -259.83 |
| Free Cash Flow | -28.78M | -28.78M | -28.17M | -24.58M | -23.74M | -12.48M |
| Free Cash Flow Per Share | -5.74 | -5.74 | -66.58 | -224.09 | -228.03 | -120.86 |
| EBITDA | -35.93M | -35.93M | -27.10M | -33.25M | -23.26M | -15.27M |
| D&A For EBITDA | 119.33K | 119.33K | 106.63K | 83.90K | 15.27K | 15.27K |
| EBIT | -36.05M | -36.05M | -27.20M | -33.33M | -23.27M | -15.29M |
Balance sheet
Fiscal year August - July; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 9.85M | 9.85M | 10.49M | 862.09K | 21.25M | 41.04M |
| Short-Term Investments | 10.69M | 10.69M | 7.37M | |||
| Cash & Short-Term Investments | 20.54M | 20.54M | 17.87M | 862.09K | 21.25M | 41.04M |
| Other Receivables | 1.50M | 1.50M | 736.36K | 24.10K | ||
| Receivables | 1.50M | 1.50M | 736.36K | 24.10K | ||
| Prepaid Expenses | 2.06M | 2.06M | 5.70M | 1.28M | ||
| Total Current Assets | 22.04M | 22.04M | 19.93M | 3.65M | 26.95M | 42.35M |
| Property, Plant & Equipment | 319.80K | 319.80K | 296.82K | 388.18K | ||
| Long-Term Investments | 730.03K | 730.03K | 524.28K | 418.49K | 2.00 | 2.00 |
| Other Intangible Assets | 169.25K | 169.25K | 184.53K | 199.80K | 215.07K | 230.34K |
| Other Long-Term Assets | 315.70K | 315.70K | 717.51K | 1.21M | ||
| Total Assets | 23.58M | 23.58M | 21.65M | 5.87M | 27.16M | 42.58M |
| Accounts Payable | 6.99M | 6.99M | 3.28M | 7.17M | 1.12M | 463.28K |
| Accrued Expenses | 987.11K | 987.11K | 694.28K | 290.38K | 677.72K | 477.81K |
| Total Current Liabilities | 7.98M | 7.98M | 3.98M | 7.46M | 1.80M | 941.09K |
| Other Long-Term Liabilities | 38.94K | 38.94K | 337.67K | 1.10M | 29.14M | 31.31M |
| Total Liabilities | 8.02M | 8.02M | 4.32M | 8.56M | 30.94M | 32.25M |
| Common Stock | 120.91M | 120.91M | 101.74M | 72.17M | 69.59M | 65.59M |
| Retained Earnings | -146.66M | -146.66M | -111.76M | -85.44M | -80.65M | -60.35M |
| Comprehensive Income & Other | 42.15M | 42.15M | 27.90M | 10.89M | 7.28M | 5.09M |
| Total Common Equity | 16.40M | 16.40M | 17.88M | -2.38M | -3.78M | 10.33M |
| Minority Interest | -841.75K | -841.75K | -546.79K | -302.52K | ||
| Shareholders' Equity | 15.56M | 15.56M | 17.33M | -2.68M | -3.78M | 10.33M |
| Total Liabilities & Equity | 23.58M | 23.58M | 21.65M | 5.87M | 27.16M | 42.58M |
| Net Cash (Debt) | 20.54M | 20.54M | 17.87M | 862.09K | 21.25M | 41.04M |
| Net Cash Per Share | 4.10 | 4.10 | 42.23 | 7.86 | 204.08 | 397.33 |
| Filing Date Shares Outstanding | 8.73M | 8.73M | 1.88M | 121.90K | 106.55K | 103.45K |
| Total Common Shares Outstanding | 8.71M | 8.71M | 1.88M | 121.90K | 106.55K | 103.45K |
| Working Capital | 14.06M | 14.06M | 15.95M | -3.81M | 25.15M | 41.41M |
| Book Value Per Share | 1.88 | 1.88 | 9.49 | -19.54 | -35.45 | 99.84 |
| Tangible Book Value | 16.23M | 16.23M | 17.70M | -2.58M | -3.99M | 10.10M |
| Tangible Book Value Per Share | 1.86 | 1.86 | 9.39 | -21.18 | -37.47 | 97.61 |
| Machinery | 456.80K | 456.80K |
Cash flow statement
Fiscal year August - July; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -34.90M | -34.90M | -26.31M | -4.79M | -20.30M | -26.84M |
| Depreciation & Amortization | 119.33K | 119.33K | 106.63K | 83.90K | 15.27K | 15.27K |
| Loss (Gain) From Sale of Investments | -92.23K | -92.23K | ||||
| Loss (Gain) on Equity Investments | 263.48K | 263.48K | 224.21K | 106.51K | ||
| Stock-Based Compensation | 1.74M | 1.74M | 776.88K | 1.80M | 2.19M | 3.07M |
| Other Operating Activities | -734.57K | -734.57K | -1.06M | -28.38M | -2.12M | 11.66M |
| Change in Accounts Receivable | -3.25K | -3.25K | 733.63K | -732.58K | 5.23K | -11.53K |
| Change in Accounts Payable | 3.71M | 3.71M | -3.89M | 6.05M | 660.46K | 249.16K |
| Change in Other Net Operating Assets | 1.25M | 1.25M | 1.25M | 1.74M | -4.20M | -628.93K |
| Operating Cash Flow | -28.65M | -28.65M | -28.17M | -24.13M | -23.74M | -12.48M |
| Capital Expenditures | -127.05K | -127.05K | -456.80K | |||
| Investment in Securities | -3.68M | -3.68M | -7.65M | -225.00K | ||
| Investing Cash Flow | -3.81M | -3.81M | -7.65M | -681.80K | ||
| Issuance of Common Stock | 31.81M | 31.81M | 45.45M | 4.42M | 4.00M | 6.51M |
| Repurchase of Common Stock | -47.29K | -10.17M | ||||
| Other Financing Activities | -80.69K | |||||
| Financing Cash Flow | 31.81M | 31.81M | 45.45M | 4.42M | 3.95M | -3.74M |
| Net Cash Flow | -641.37K | -641.37K | 9.63M | -20.39M | -19.79M | -16.23M |
| Free Cash Flow | -28.78M | -28.78M | -28.17M | -24.58M | -23.74M | -12.48M |
| Free Cash Flow Per Share | -5.74 | -5.74 | -66.58 | -224.09 | -228.03 | -120.86 |
| Levered Free Cash Flow | -17.98M | -17.98M | -18.89M | -10.83M | -15.87M | -6.86M |
| Unlevered Free Cash Flow | -17.98M | -17.98M | -18.87M | -10.83M | -15.87M | -6.86M |
| Change in Working Capital | 4.96M | 4.96M | -1.91M | 7.05M | -3.53M | -391.29K |
Ratios
Fiscal year August - July; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 27.78M | 29.89M | 12.81M | 13.63M | 106.43M | 101.46M |
| Enterprise Value | 6.28M | 7.13M | -105.70K | 12.44M | 77.39M | 56.94M |
| Last Close Price | 3.04 | 3.44 | 7.46 | 112.87 | 1,003.50 | 975.00 |
| PB Ratio | 1.72 | 1.92 | 0.74 | -5.08 | -28.18 | 9.82 |
| P/TBV Ratio | 1.65 | 1.84 | 0.72 | 10.05 | ||
| Net Debt / Equity Ratio | -1.32 | -1.32 | -1.03 | 0.32 | 5.63 | -3.97 |
| Net Debt / EBITDA Ratio | 0.57 | 0.57 | 0.66 | 0.03 | 0.91 | 2.69 |
| Net Debt / FCF Ratio | 0.71 | 0.71 | 0.63 | 0.04 | 0.90 | 3.29 |
| Quick Ratio | 2.76 | 2.76 | 4.49 | 0.21 | 11.80 | 43.64 |
| Current Ratio | 2.76 | 2.76 | 5.01 | 0.49 | 14.96 | 45.00 |
| Return on Equity (ROE) | -214.79% | -214.79% | -362.56% | -619.75% | -141.25% | |
| Return on Assets (ROA) | -99.64% | -99.64% | -123.56% | -126.11% | -41.71% | -18.99% |
| Return on Capital Employed (ROCE) | -231.10% | -231.10% | -153.90% | 2,097.70% | -91.80% | -36.70% |
| Earnings Yield | -221.83% | -116.77% | -205.42% | -35.14% | -19.08% | -26.45% |
| FCF Yield | -107.34% | -96.28% | -219.93% | -180.31% | -22.31% | -12.30% |
| Buyback Yield / Dilution | -1,084.29% | -1,084.29% | -285.70% | -5.35% | -0.81% | -242.82% |